KENDALL< HERE"S THE INFORMATION YOU REQUESTED> GOOD LUCK> TBL> LILLIAN
69% Summary of shark cartilage research, details on brain tumor clinical t...
URL: http://www.drlane.com/wwwboard/messages/980.htm
Summary: Rapidly spreading cancers, like glioblastomas, are thought to involve
a have a high rate of
new blood vessel development, making this type of cancer a logical candidate
for antiangiogenic
therapies like shark cartilage. : In most patients with glioblastomas, the
"proven" therapies are
unfortunately proven to have a low probability of success, but almost always
cause adverse side.
More Like This: Click here to perform a search for documents like this one.
69% Re: Clinical trials
URL: http://www.drlane.com/wwwboard/messages/690.htm
Summary: [ Follow Ups ] [ Post Followup ] [ The Shark Cartilage Message Forums
] [ FAQ ]
Posted by Ann on November 02, 1997 at 13:20:14: In Reply to: Clinical trials
posted by Mike on
October 30, 1997 at 16:52:59:. I called 1800 4 CANCER and they said that trials
had shown no
evidence that Benefin was helping to slow tumor growth.
More Like This: Click here to perform a search for documents like this one.
69% Summary of research, clinical trials recruiting patients
URL: http://www.drlane.com/wwwboard/messages/981.htm
Summary: Rapidly spreading cancers, like glioblastomas, are thought to involve
a have a high rate of
new blood vessel development, making this type of cancer a logical candidate
for antiangiogenic
therapies like shark cartilage. Rapidly spreading cancers, like glioblastomas,
are thought to involve a
have a high rate of new blood vessel development, making this type of cancer a
logical candidate for.
More Like This: Click here to perform a search for documents like this one.
69% Books
URL: http://www.gen.com/healingnet/books.htm
Summary: Dr Lane provides photographic evidence on the effects in tumor tissues
by the
administration of shark cartilage, results of the "Cuban" clinical trials at 40
months, details on new
clinical trials and profiles of patients, doctors, and scientists. SHARK
CARTILAGE: A PROMISE
KEPT This video documantary explains the use of shark cartilage through
interviews with patients
who are.
More Like This: Click here to perform a search for documents like this one.
69% Re: Glioblastoma Multiforme /ANY INFO... PLEASE!!
URL: http://www.drlane.com/WWWBOARD/messages/1922.htm
Summary: A. allowed Phase II clinical trials are underway in the Hackensack
University Medical
Center using clinical quality shark cartilage for the treatment of previously
non-responsive brain
tumors (for details on the clinical trial please call 1-800-997-7844). F.D.A.
allowed Phase II clinical
trials are underway in the Hackensack University Medical Center using clinical
quality shark.
More Like This: Click here to perform a search for documents like this one.
69% Shark Cartilage from Body Systems Technology
URL: http://www.aaaab.com/shark.html
Summary: Shark Cartilage is a natural nontoxic substance that has been shown to
inhibit tumor
growth, as evidenced by published laboratory studies conducted by eminent
scientists over a thirty
year period. In three case, the tumors had become encapsulated, and in two
cases in which the
tumors had become attached to the chest wall, they had become detached and free
floating.
More Like This: Click here to perform a search for documents like this one.
69% SHARK
URL: http://www.subnet.com/FLEET/ssn591.htm
Summary: SHARK participated in SUBFALLEX in the North Atlantic from 7 August to
24
October, with a week spent in Faslane, Scotland. On 11 June 1967, SHARK
prepared for her first
refueling period at the Norfolk Naval Shipyard and did not put to sea again
until March 1968.
More Like This: Click here to perform a search for documents like this one.
Page
www.graylab.ac.uk
NCI Surgery Branch Trials
NCI Surgery Branch Trials CancerNet from the
National Cancer Institute CancerNet News The
Surgery Branch of the National Cancer Institute de
http://www.graylab.ac.uk/cancernet/400081.html
More Like This
www.meb.uni-bonn.de
NCI Surgery Branch Trials
NCI medNews "NCI Surgery Branch Trials" is
redistributed by University of Bonn, Medical Center
NCI Surgery Branch Trials Get this
http://www.meb.uni-bonn.de/cancernet/400081.html
More Like This
www.salick.com
Cancer Sites: Liver Cancer
LIVER CANCER ONCOLINK ® Liver Cancer University
of Pennsylvania Cancer Center general information
medical supportive care related artic
http://www.salick.com/resource/sitel03.html
More Like This
cancer.med.upenn.edu
OncoLink: Liver Cancer
About OncoLink Editorial Board Sponsors Printing
FAQ Help Usage Statistics Virtual Classroom
Abramson Family Cancer Research Institute "Conf
http://cancer.med.upenn.edu/disease/liver/index.html
More Like This
oncolink.upenn.edu
OncoLink: Liver Cancer
About OncoLink Editorial Board Sponsors Printing
FAQ Help Usage Statistics Virtual Classroom
Abramson Family Cancer Research Institute "Conf
http://oncolink.upenn.edu/disease/liver/index.html
More Like This
NCI CancerLit News: NCI Surgical Oncology
Branch Trials - Up
About OncoLink Editorial Board Sponsors Printing
FAQ Help See Today's OncoTip Usage Statistics
Virtual Classroom Abramson Family Cancer Rese
http://oncolink.upenn.edu/pdq_html/4/engl/400081.html
More Like This
NCI/PDQ Patient Statement: Colon cancer -
Updated 12/97
About OncoLink Editorial Board Sponsors Printing
FAQ Help See Today's OncoTip Usage Statistics
Virtual Classroom Abramson Family Cancer Rese
http://oncolink.upenn.edu/pdq_html/2/engl/200008.html
More Like This
NCI/PDQ CancerLit Search: THERAPY OF
OVARIAN CANCER - Februa
NCI/PDQ CancerLit Search: THERAPY OF OVARIAN
CANCER - February 1996 -
**********************************************************************
http://oncolink.upenn.edu/cancernet/96/feb/702211.html
More Like This
cancernet.nci.nih.gov
childhood liver cancer
PDQ Clinical Trials pertaining to: childhood liver
cancer Phase II Study of Myeloablative Chemotherapy
with TSPA/CBDCA with Bone Marrow Resc
http://cancernet.nci.nih.gov/prot/menu/dx00963.html
More Like This
www.oncolink.upenn.edu
NCI CancerLit News: NCI Surgical Oncology
Branch Trials - Up
About OncoLink Editorial Board Sponsors Printing
FAQ Help Usage Statistics Virtual Classroom
Abramson Family Cancer Research Institute "Conf
http://www.oncolink.upenn.edu/pdq_html/4/engl/400081.ht
More Like This
www.noah.cuny.edu
Liver metastases (Physician)
[Home][Español] Ask NOAH About: Cancer Liver
metastases 208/03856 CancerNet: National Cancer
Institute PDQ Information for Health Care Profe
http://www.noah.cuny.edu/cancer/nci/cancernet/103856.ht
More Like This
www.noah.cuny.edu
Liver metastases (Physician)
[Home][Español] Ask NOAH About: Cancer Liver
metastases 208/03856 CancerNet: National Cancer
Institute PDQ Information for Health Care Profe
http://www.noah.cuny.edu/cancer/nci/cancernet/103856.ht
More Like This
www.noah.cuny.edu
Liver metastases (Physician)
[Home][Español] Ask NOAH About: Cancer Liver
metastases 208/03856 CancerNet: National Cancer
Institute PDQ Information for Health Care Profe
http://www.noah.cuny.edu/cancer/nci/cancernet/103856.ht
More Like This
cancernet.nci.nih.gov
Meta... article, issue 5, vol 88, jnci, 1996
ARTICLE Reappraisal of Hepatic Arterial Infusion in
the Treatment of Nonresectable Liver Metastases
From Colorectal Cancer Meta-Analysis Gro
http://cancernet.nci.nih.gov/jnci/iss8805/88-252.html
More Like This
Matt Leigh wrote:
> Lillian, Thank you for the words of encouragement. My dad does have a VERY
> positive attitude and surrounds himself with the same type of people, we are
> very grateful for all of his wonderful friends and supportive wife. We know
> that he can beat this, we just have to figure out how! If any one out there
> is using the "Shark Cartilage" please let me know also if you have any
> information on it. When I am looking for it on the web, I am only coming up
> with people who sell it and not so much the effects of it. The clinical
> trials sound interesting, I would like to learn more so that I can pass the
> information on. Thanks, Kendall
> -----Original Message-----
> From: lillian jennings <firefly@islc.net>
> To: mol-cancer@lists.meds.com <mol-cancer@lists.meds.com>
> Date: Sunday, August 30, 1998 10:12 PM
> Subject: Re: [MOL] Welcome Kendall
>
> >Sender: owner-mol-cancer@a5.inet911.com
> >Received: from a5.inet911.com (a5.inet911.com [199.242.194.16])
> > by dub-img-9.compuserve.com (8.8.6/8.8.6/2.12) with ESMTP id BAA05632;
> > Mon, 31 Aug 1998 01:11:44 -0400 (EDT)
> >Received: (from majordom@localhost)
> > by a5.inet911.com (8.9.0.Beta5/8.8.5) id BAA03833
> > for mol-cancer-outgoing; Mon, 31 Aug 1998 01:40:49 -0400
> >X-Authentication-Warning: a5.inet911.com: majordom set sender to
> owner-mol-cancer@lists.meds.com using -f
> >Received: from islc.net (root@[208.224.174.10])
> > by a5.inet911.com (8.9.0.Beta5/8.8.5) with ESMTP id BAA03830
> > for <mol-cancer@lists.meds.com>; Mon, 31 Aug 1998 01:40:44 -0400
> >Received: from islc.net (p219.islc.net [208.224.174.219]) by islc.net
> (8.8.5/8.7.3) with ESMTP id BAA21212 for <mol-cancer@lists.meds.com>; Mon,
> 31 Aug 1998 01:04:28 -0400 (EDT)
> >Message-ID: <35EA2B17.415A07EE@islc.net>
> >Date: Mon, 31 Aug 1998 00:48:24 -0400
> >From: lillian jennings <firefly@islc.net>
> >X-Mailer: Mozilla 4.04 [en] (Win95; I)
> >MIME-Version: 1.0
> >To: mol-cancer@lists.meds.com
> >Subject: Re: [MOL] Welcome Kendall
> >References: <005901bdd486$43be67e0$c6889ad1@home>
> >Content-Type: text/plain; charset=us-ascii
> >Content-Transfer-Encoding: 7bit
> >Sender: owner-mol-cancer@lists.meds.com
> >Precedence: bulk
> >Reply-To: mol-cancer@lists.meds.com
> >
> >I am not the God send, this forum you lucked upon is a God send though and
> surly
> >is a safe haven for one to speak openly, to question, to rant, what ever
> and be
> >understood. The forum represents all forms of cancers and the folks on it
> are
> >so loving. We comprise of survivors, those in treatment, caregivers, and
> love
> >one's of those cancering; so it would be beneficial for you to join in any
> of
> >the on going conversations and make friends. This is how all of us acquire
> the
> >knowledge that is needed to make good judgements. We are expierenced in
> helping
> >one go through this journey, the ups along with the downs. So Welcome!
> Kendall
> >there are a few ground rules to help your father. He must rid himself of
> >toxins, including doxic friends. He needs to learn and others around him,
> not
> >to be stressed. A positive outlook is very important...he should build his
> >immune system. Now, none of us are doctors; however our opinions are from
> >expierence and are just that opinions. What may work well for some, may
> not
> >work at all for other's. There are some other options that may want to be
> >explored and they are: freezing tumors, gamma knife surgery, lazer and
> most
> >likely some I am not aware of; but other's on line are.
> >We find that alternative therapy works well with traditional therapy. MD
> >Anderson Hos. and I already sent you that site e-mail address has been
> doing
> >trials on some alternative meds. Also your father may want to think about
> >entering a trial; where they are working with the very latest of meds. and
> >treatments. I can give you the site to find out about trials, just let me
> >know. Kendall, I know you are in a state of shock right now, it is hard
> when
> >one thinks about the possibility of loosing their loved one. Pls. work on
> >positive thinking every day, something like "I will not loose my dad, we
> will
> >fight this togeather. Take care and let me know if I can help you further;
> but
> >do pls. join in with this wonderful group......TBL lillian
> >Matt Leigh wrote:
> >
> >> Lillian, Thank you so much for the information you sent, it was very
> >> informative. This is probably the hardest thing I've ever had to deal
> with.
> >> My dad is so young and has always been so healthy (he doesn't smoke,
> works
> >> out every day and eats very healthy). I keep asking myself why him? He
> >> just got back from New York after a 3 month treatment with some kind of
> >> injection directly into the tumor, Dr. Order has had a lot of success
> with
> >> this treatment (he specializes on the live and pancreas). Unfortunately
> >> this did not work on my father, they feel mainly because they were only
> able
> >> to get one injection in (it leaked) so they could not do the second
> >> injection. When he left New York a month ago his numbers were at 425,
> last
> >> week they were back up at 1400. The oncologist said they could not
> operate,
> >> so he is now looking at other options. He just started back on the shark
> >> cartilage, so maybe that will help. Do you know anything about that? I
> am
> >> sorry to be rambling on, but I feel like you were a real find. I can't
> seem
> >> to get the answers any where else. I am 32 years old and my dad is my
> best
> >> friend, I don't want to lose him! Thank you again for all your help. I
> >> will continue to check in daily and appreciate any information you can
> give.
> >> Thanks, Kendall
> >> -----Original Message-----
> >> From: lillian jennings <firefly@islc.net>
> >> To: mol-cancer@lists.meds.com <mol-cancer@lists.meds.com>
> >> Date: Sunday, August 30, 1998 10:58 AM
> >> Subject: Re: [MOL] Intravenious octrietide treatment for cancer
> >>
> >> >Sender: owner-mol-cancer@a5.inet911.com
> >> >Received: from a5.inet911.com (a5.inet911.com [199.242.194.16])
> >> > by hil-img-1.compuserve.com (8.8.6/8.8.6/2.12) with ESMTP id NAA04477;
> >> > Sun, 30 Aug 1998 13:57:13 -0400 (EDT)
> >> >Received: (from majordom@localhost)
> >> > by a5.inet911.com (8.9.0.Beta5/8.8.5) id OAA31647
> >> > for mol-cancer-outgoing; Sun, 30 Aug 1998 14:26:07 -0400
> >> >X-Authentication-Warning: a5.inet911.com: majordom set sender to
> >> owner-mol-cancer@lists.meds.com using -f
> >> >Received: from islc.net (root@[208.224.174.10])
> >> > by a5.inet911.com (8.9.0.Beta5/8.8.5) with ESMTP id OAA31644
> >> > for <mol-cancer@lists.meds.com>; Sun, 30 Aug 1998 14:26:01 -0400
> >> >Received: from islc.net (p113.islc.net [208.224.174.113]) by islc.net
> >> (8.8.5/8.7.3) with ESMTP id NAA04340 for <mol-cancer@lists.meds.com>;
> Sun,
> >> 30 Aug 1998 13:49:48 -0400 (EDT)
> >> >Message-ID: <35E98CFB.602F1408@islc.net>
> >> >Date: Sun, 30 Aug 1998 13:33:47 -0400
> >> >From: lillian jennings <firefly@islc.net>
> >> >X-Mailer: Mozilla 4.04 [en] (Win95; I)
> >> >MIME-Version: 1.0
> >> >To: mol-cancer@lists.meds.com
> >> >Subject: Re: [MOL] Intravenious octrietide treatment for cancer
> >> >References: <000701bdd432$fc455f20$6e619ad1@home>
> >> >Content-Type: multipart/alternative;
> >> boundary="------------BB9E8C0E5D0B21BEE916CED0"
> >> >Sender: owner-mol-cancer@lists.meds.com
> >> >Precedence: bulk
> >> >Reply-To: mol-cancer@lists.meds.com
> >> >
> >> >Matt: Welcome to our wonderful forum, a home away from home. I was not
> >> >able to find anything on octrietide treatment and hope one of our other
> >> >members will be able to answer your question. Your friend, Lillian
> >> >
> >> >Matt Leigh wrote:
> >> >
> >> >> I am looking for information regarding intravenous octrietide
> >> >> treatment for my father who has been diagnosed with neuroindrican
> >> >> cancer of the pancreas. He is 54 years old and in very good health.
> >> >> He exercises every day and is feeling great, but still the cancer is
> >> >> there. Surgery is not an option, so we have been told about this
> >> >> octrietide. If you have any information, please e-mail me at
> >> >> flyfish@CompuServe. Thank you.
> >> >
> >> >
> >> >
> >>
> >> ------------------------------------------------------------------------
> >> This is an automatically-generated notice. If you'd like to be removed
> >> from the mailing list, please visit the Medicine-On-Line Discussion Forum
> >> at <http://www.meds.com/con_faq.html>, or send an email message to:
> >> majordomo@lists.meds.com
> >> with the subject line blank and the body of the message containing the
> line:
> >> unsubscribe mol-cancer your-email-address
> >> where the phrase your-email-address is replaced with your actual email
> >> address.
> >> ------------------------------------------------------------------------
> >
> >
> >
> >------------------------------------------------------------------------
> >This is an automatically-generated notice. If you'd like to be removed
> >from the mailing list, please visit the Medicine-On-Line Discussion Forum
> >at <http://www.meds.com/con_faq.html>, or send an email message to:
> >majordomo@lists.meds.com
> >with the subject line blank and the body of the message containing the
> line:
> >unsubscribe mol-cancer your-email-address
> >where the phrase your-email-address is replaced with your actual email
> >address.
> >------------------------------------------------------------------------
> >
>
> ------------------------------------------------------------------------
> This is an automatically-generated notice. If you'd like to be removed
> from the mailing list, please visit the Medicine-On-Line Discussion Forum
> at <http://www.meds.com/con_faq.html>, or send an email message to:
> majordomo@lists.meds.com
> with the subject line blank and the body of the message containing the line:
> unsubscribe mol-cancer your-email-address
> where the phrase your-email-address is replaced with your actual email
> address.
> ------------------------------------------------------------------------
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
